insights_auto
Why is SCNI up 6.03%?
Dive Deeperchevron_right
SCNI:NASDAQ
Scinai Immunotherapeutics Ltd - ADR
$1.23
arrow_upward
+6.03%(+0.070) 1D
$1.12
arrow_downward
-8.94% (-0.11)todayPre-market
Closed: Oct 13, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SCNI...
Open
$1.56
High
$1.76
Low
$1.14
Mkt. cap
701.13K
Avg. vol.
2.25M
Volume
167.36K
52-wk high
$15.65
52-wk low
$1.06
EPS
-$2.80
Beta
2.13
Shares outstanding
706.59K
No. of employees
45
Open
$1.56
High
$1.76
Low
$1.14
Mkt. cap
701.13K
Avg. vol.
2.25M
Volume
167.36K
52-wk high
$15.65
52-wk low
$1.06
EPS
-$2.80
Beta
2.13
Shares outstanding
706.59K
No. of employees
45
News stories
From web sources and news partners
StocksToTrade
·
16 hours ago
SCNI Stock Holds Nasdaq Compliance As Traders Refocus On Pipeline
Timothy Sykes
·
16 hours ago
SCNI Regains Nasdaq Compliance As Traders Reassess Risk
Benzinga
·
18 hours ago
Why Is Scinai Immunotherapeutics Stock Gaining Tuesday?
Benzinga
·
18 hours ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Profile
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
About Scinai Immunotherapeutics Ltd - ADR